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Abstract
 
Malaria parasite species that infect mammals, including humans, must first take up residence in
hepatic host cells as exoerythrocytic forms (EEF) before initiating infection of red blood cells
that leads to malaria disease. Despite the importance of hepatic stages for immunity against ma-
laria, little is known about their biology and antigenic composition. Here, we show that sporo-
zoites, the parasites’ transmission stage that resides in the mosquito vector salivary glands, can
transform into early EEF without intracellular residence in host hepatocytes. The morphologi-
cal sequence of transformation and the expression of proteins in the EEF appear indistinguish-
able from parasites that develop within host cells. Transformation depends on temperature ele-
vation to 37
 
 
 
C and serum. Our findings demonstrate that residence in a host hepatocyte or
specific host cell–derived factors are not necessary to bring about the profound morphological
 
and biochemical changes of the parasite that occur after its transmission from vector to
mammalian host.
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Introduction
 
Malaria is caused by obligate intracellular protozoan para-
sites of the genus 
 
Plasmodium
 
. Plasmodia have a complex
life cycle that alternates between mosquito vector and ver-
tebrate host. Transmission occurs when infected mosqui-
toes bloodfeed and inoculate sporozoites. After entering
the bloodstream, sporozoites are quickly transported to the
liver where they extravasate and subsequently invade hepa-
tocytes. Within host hepatocytes, the elongate sporozoites
transform into spherical hepatic stages (exoerythrocytic
forms [EEF]). EEF are the obligatory intermediary tissue
stage between the parasites’ residence in the mosquito vec-
tor and the initiation of red blood cell infection by mero-
zoites in the mammalian host (1). Transformation is a radi-
cal cellular remodeling process (2). It becomes first
discernible by a bulbous expansion of the sporozoite that
contains the single nucleus. This bulb progressively enlarges
until the banana-shaped sporozoite is completely absorbed.
The spherical EEF grow, undergo multiple rounds of nu-
clear division (3), and finally differentiate into thousands of
first generation merozoites. It is not known what signals
trigger transformation into hepatic stages and what factors
are essential to support it.
 
Plasmodium
 
 hepatic stages are exceedingly difficult to
study because they are rare and preparations are always
contaminated with hepatocyte material. Therefore, little is
known about their antigenic repertoire with only a few
EEF-expressed proteins identified (4). However, defining
antigens expressed in early liver stages is an important goal
for preerythrocytic vaccine development (5). Complete
development of hepatic stages of 
 
Plasmodium berghei
 
, a
model 
 
Plasmodium
 
 species that infects rodents, has been
achieved in vitro using the hepatoma cell line HepG2 as a
host cell (6). This in vitro system, together with a line of
 
P. berghei
 
 that expresses green fluorescent protein (GFP;
reference 7), facilitates microscopic monitoring of invasion
and subsequent EEF development. In HepG2 culture in-
fections, we frequently observed extracellular sporozoites
that transformed into EEF and were still detectable after
24 h in culture. Thus we investigated the potential of
sporozoites to transform into early hepatic stages in the ab-
sence of host hepatocytes.
 
Materials and Methods
 
Parasites. 
 
4–5-d-old female 
 
Anopheles stephensi
 
 mosquitoes
were blood-fed on anesthetized Swiss CD-1/ICR mice infected
with wild-type 
 
P. berghei
 
 strain NK65 or a GFP-expressing 
 
P.
berghei
 
 NK65 line. Rodents were assayed for high levels of para-
sitemia and the abundance of gametocyte-stage parasites capable
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of exflagellation. Afterwards, the infective bloodmeal mosquitoes
were maintained at 21
 
 
 
C, 80% humidity. On day 10 after feed-
ing, the mosquitoes were dissected in RPMI 1640, and the iso-
lated midguts were examined for the infection rate. Only mos-
quito cages having at least 70% of infected mosquitoes were kept
for further analysis. Mosquitoes were rinsed in 70% ethanol for 5
min and washed twice in sterile medium to reduce contamina-
tion. Salivary glands were dissected in sterile DMEM (BioWhit-
taker) containing 500 U/ml penicillin–streptomycin and 1.25 
 
 
 
l/
ml fungizone (Sigma-Aldrich). The glands were disrupted, and
the sporozoites were isolated and counted in a hemocytometer.
 
Transformation Medium and Quantification of Transformation.
 
Sporozoites were suspended in DMEM containing 2 mM
 
l
 
-glutamine and 4.5 g/liter glucose, and supplemented with 10%
FBS (HyClone Laboratories), 500 U/ml penicillin–streptomy-
cin, and 1.25 
 
 
 
l/ml fungizone. 5 
 
 
 
 10
 
4
 
 sporozoites were inocu-
lated per well of 8-well chamber slides (Labtek) and maintained
at 37
 
 
 
C in 5% CO
 
2
 
. Initially, the slides were coated with Matri-
gel (Becton Dickinson) at 100 
 
 
 
g/cm
 
2
 
 density to improve the
development. Matrigel improved the attachment of the parasite
to the slide, but it was not essential for transformation. To deter-
mine transformation rates for various conditions, slides were ex-
amined by fluorescence microscopy at 400
 
  
 
using 
 
P. berghei
 
–
expressing GFP. EEF were scored as completely transformed only
when they appeared completely spherical with no visible sporo-
zoite remnants. Each count was performed in triplicate on three
independent experiments done with sporozoites isolated from
different batches of infected mosquitoes. As a control, 
 
P. berghei
 
was cultivated in HepG2-A16 cells (HB 8065; American Type
Culture Collection).
 
Immunofluorescence Assays. 
 
Transformation was confirmed by
immunofluorescence assay using monoclonal antibodies against
heat shock protein 70 (HSP70), circumsporozoite protein
(CSP), thrombospondin-related anonymous protein (TRAP),
and a rabbit polyclonal antibody against myosin A tail domain
interacting protein (MTIP), an inner membrane complex–asso-
ciated protein. Parasites were removed from culture chambers,
fixed in 2% paraformaldehyde, washed in PBS, concentrated by
centrifugation, suspended in 1% FBS/PBS-diluted primary anti-
body, and incubated at 37
 
 
 
C for 1 h. After three washes, the
samples were incubated in 40 
 
 
 
g/ml 6-diamidino-2-phenyl-
lindole (DAPI) for 30 min at room temperature. After three
washes in 1% FBS/PBS, the parasites were transferred onto 12-
well slides and dried at room temperature. Slides were incubated
with secondary antibodies conjugated with Alexa Fluor 488 or
Alexa Fluor 594 (Molecular Probes) and diluted 1:250 in 1%
FBS/PBS for 1 h at 37
 
 
 
C.
 
Immunoblot. 
 
8 
 
 
 
 10
 
5
 
 salivary gland sporozoites and the con-
tent of chambers inoculated with the same number of sporozoites
and maintained for 24 h at 37
 
 
 
C were collected. The transforma-
tion rate for this batch was 13%. Samples were suspended in 10 
 
 
 
l
of SDS loading buffer and incubated for 5 min at 70
 
 
 
C. Antigen
extracts were subjected to 7% SDS-PAGE and transferred onto a
polyvinyldifluoride membrane. The membrane was blocked
overnight at 4
 
 
 
C in PBS containing 5% dry milk, and incubated
for 1 h with anti-HSP70 antibody. The membrane was washed in
PBS/0.1% Tween 20 and incubated for 1 h with 1:5,000 diluted
horseradish peroxidase–labeled anti–mouse IgG (Amersham Bio-
sciences) and developed with enhanced chemiluminescence
(ECL; Amersham Biosciences).
 
Reverse Transcriptase (RT)–PCR. 
 
5 
 
 
 
 10
 
5
 
 
 
P. berghei
 
 sporo-
zoites were inoculated on 12-well plates and placed at 37
 
 
 
C or
22
 
 
 
C. 24 h after inoculation, the content of each well was col-
 
lected, and total RNA extraction was performed using the RN-
easy Mini kit (QIAGEN). RNA was treated with DNase I (Invit-
rogen) to remove contaminating genomic DNA. First strand
cDNA synthesis was done using an RT-PCR kit (PE Applied
Biosystems) with random hexamers. PCR amplification was done
using oligonucleotide primers specific for the 
 
P. berghei
 
 A type
rRNA (sense, 5
 
 
 
-CGAGAATCTTGGCTCCGCCTCG-3
 
 
 
;
antisense 5
 
 
 
 CTAAGAAATCCCCGAAGGGAAATC-3
 
 
 
). This
amplified a specific 460-bp fragment. 
 
P. berghei
 
 S type rRNA was
amplified using oligonucleotide primers (sense, 5
 
 
 
-CATGACT-
TCTGTCACTGCTTTTATC-3
 
 
 
; antisense-5
 
 
 
-CTACTCCT-
TAAAGAAGATAGTT-3
 
 
 
). This amplified a specific 457-bp
fragment. PCR was done for 30 cycles of 95
 
 
 
C for 15 s, 58
 
 
 
C for
30 s, and 72
 
 
 
C for 3 min.
PCR amplification for merozoite surface protein-1 (MSP-1)
was done using oligonucleotide primers (sense, 5
 
 
 
-GGAG-
AAAATGCAGTGGTAAG-3
 
 
 
; antisense 5
 
 
 
-TTTTAAATGC-
CTCAAGAATATTTTTTTCT-3
 
 
 
). This amplified a specific
120-bp fragment. PCR amplification for HEP17 was done using
oligonucleotide primers (sense, 5
 
 
 
-AAAAGGGAAGACATC-
CATTC-3
 
 
 
; antisense-5
 
 
 
-TGTATTCCTTCGGATGAAAAA-
3
 
 
 
). This amplified a specific 120-bp fragment. PCR was done
for 30 cycles of 95
 
 
 
C for 15 s, 55
 
 
 
C for 30 s, and 72
 
 
 
C for
3 min.
 
Results and Discussion
 
To test if sporozoites can transform in the absence of
host cells, they were cultured without HepG2 cells in mi-
crochamber slides coated with basement membrane extract
(Matrigel) and DMEM containing 10% FBS for 4, 10, and
24 h at 37
 
 
 
C. Microscopic examination showed that after
4 h, sporozoites frequently developed the transformation
bulb (Fig. 1 A) that was also typically observed during early
intracellular transformation (2). At 10 h, the extracellular
transformation had proceeded further to intermediate EE-
like forms displaying a more extended bulb and further re-
traction of the armlike remnants of the sporozoite cell body
(Fig. 1 B), closely resembling the progression of transfor-
mation observed during intracellular transformation (3, 8).
At 24 h, 
 
 
 
13% of sporozoites had transformed into com-
pletely spherical EE-like forms (Fig. 1, C–E, and Table I).
This rate of transformation exceeds the published rates of
transformation achieved in HepG2 cells, which range from
3 to 8% (6, 9) and the rates of transformation in HepG2
cells observed by us (
 
 
 
5%, unpublished data). EE-like
forms that were cultured without HepG2 cells were similar
in size (6–10 µm) and morphology when compared with
EEF that grew within HepG2 cells (Fig. 1, F–H). No
sporozoites were detectable in 24-host cell–free cultures,
indicating that untransformed sporozoites did not survive.
We tested if expression of EEF proteins is comparable
between EEF that undergo intracellular development and
EE-like forms that develop without host cells, using anti-
bodies against HSP70, CSP, TRAP, and MTIP. Although
HSP70 of 
 
Plasmodium
 
 is highly expressed in EEF and
erythrocytic stages of the parasite, it is barely detectable in
sporozoites (10–12). Therefore, HSP70 expression can be
used to follow the transformation of sporozoites into he-
patic stages. After 6 h, early extracellular EE-like formsT
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identified by the transformation bulb showed increasing
HSP70 expression (Fig. 2 A). After 18–24 h, completely
spherical EE-like forms had developed that showing in-
tense HSP70 staining (Fig. 2 B). When cultures were incu-
bated for 48 h, most of these early EE-like forms seemed
not to develop further, but a few EE-like forms showed
significant increase in size and compartmentalization of
HSP70 staining (Fig. 2 C). This might correspond to the
cytoplasmic compartmentalization observed in intracellular
EEF at this time point (13). HSP70 staining patterns
closely resembled the staining patterns of intracellular EEF
developing inside HepG2 cells. Up-regulation of HSP70
expression was confirmed by immunoblot analysis (Fig. 2
D). HSP70 expression was barely detectable in protein ex-
tracts of 800,000 salivary gland sporozoites. However, ex-
pression increased dramatically when the same number of
parasites where cultured in the host cell–free system for
24 h (13% transformation rate). HSP70 expression might
be induced by temperature elevation, the transformation
Figure 1. Transformation of Plasmodium sporozoites into EEF does not
require host cells. P. berghei sporozoites and EEF express green fluorescent
protein enabling the visualization of live parasites. (A–E) Sporozoites cul-
tured at 37 C without HepG2 cells transform through the classic se-
quence of morphological changes into EE trophozoites. (A) After 4 h of
culture, many parasites exhibit the transformation bulb (arrows), which is
the first morphological indication of transformation. (B) After 10 h of cul-
ture, parasites have progressed further in transformation, as indicated by
enlargement of the transformation bulb and concurrent retraction of the
armlike sporozoite remnants (arrows). The insets show transforming para-
sites at higher magnification. After 24 h, (C–E) spherical trophozoites
have developed that are indistinguishable from (F–H) trophozoites that
developed within host cells. Micrographs A–D, F, and G are GFP fluores-
cence images; E and H are differential interference contrast images (DIC)
showing the same trophozoites as in D and G, respectively. Bars, 10 µm.
 
Table I. 
 
Host Cell–free Transformation into Hepatic Stages
 
Conditions
 
a
 
Spherical
trophozoites
 
b
 
Transformation
 
c
 
 
 
C%
 
37 6,725.34 13.43
22  34.67 0.07
22 
 
→
 
 37 9,656 19.32
37 w/o FBS  346.67 0.69
 
a
 
24-h cultures, except 22 
 
→
 
 37
 
 
 
C, shift is 48 h; (Materials and Methods
for culture conditions).
 
b
 
Average number from three independent experiments. Parasites were
scored as completely transformed when they appeared spherical with no
sporozoite remnants visible. (Fig. 1 D).
 
c
 
Percentage of transformation was calculated based on the 5 
 
 
 
 10
 
4
 
sporozoites used for culture.
Figure 2. EEF cultured without host cells express key antigens. (A–C)
Different stages of EEF development show increased expression of
HSP70. (A) Early 6-h EEF showing the typical transformation bulb.
HSP70 expression is mostly localized to the bulb. (B) Spherical 18-h EE
trophozoite showing intense HSP70 expression. (C) Large 48-h EEF
showing compartmentalization of HSP70 staining. Micrographs on the
right show the corresponding DIC images. (D) Western blot analysis of
HSP70 expression. Sporozoites (Spz) express HSP70 at barely detectable
levels. Host cell-free EEF, cultured for 24 h, show a dramatic increase in
HSP70 expression. (E) Spherical 24-h EE trophozoite showing surface
expression of circumsporozoite (CS) protein. (F) Spherical 24-h EE tro-
phozoites do not express TRAP. Nuclei in E and F are visualized with
DAPI. (G) EEF grown for 24 h without host cells express transcripts en-
coding MSP-1 (left) and HEP17 (right). RT-PCR with gene-specific oli-
gonucleotide primers amplified specific fragments of 120 base pairs (bp).
Controls are PCR reactions without prior RT. Bars, 5 µm.T
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event itself, or both. However, because parasites kept at
37
 
 
 
C for 24 h either transformed or died, it was not possi-
ble to investigate this further.
CSP, the major sporozoite surface protein (14), is in-
volved in sporozoite host cell recognition. It is also ex-
pressed on the plasma membrane of early EEF (15, 16)
and might fulfill additional functions during hepatic stage
development. Robust CSP surface expression was de-
tected on EE-like forms cultured in the absence of host
cells for 24 h using a monoclonal antibody specific for
CSP (Fig. 2 E; reference 17). In contrast, TRAP, a sporo-
zoite micronemal protein involved in host cell invasion
(18), was not detectable on spherical EE-like forms at this
time (Fig. 2 F). The loss of TRAP expression coincides
with the disappearance of micronemes after sporozoite
transformation in vivo (3). We also determined that 
 
P.
berghei
 
 EE-like forms cultured in the absence of host cells
for 24 h expressed transcripts (Fig. 2 G) encoding MSP-1
(19), and the hepatic and erythrocytic stage protein 17
(HEP17; reference 20).
Apicomplexan zoites, including the 
 
Plasmodium
 
 sporozo-
ite, are delimited by a tri-laminar pellicle consisting of a
plasma membrane and two closely aligned inner mem-
branes that form the inner membrane complex (IMC). Af-
ter hepatocyte invasion, the sporozoite plasma membrane
becomes the EEF plasma membrane; however, the IMC is
disassembled and is not detectable at 
 
 
 
30 h after invasion
(3). Dismantling the IMC might be essential for entry of
the parasite into the trophic phase because its rigidity could
interfere with growth. MTIP localizes to the IMC of
sporozoites (21) and can serve as a marker to follow the loss
of the IMC during hepatic stage development. Dual fluo-
rescence assays with antibodies against CSP and MTIP
showed that the IMC was lost in EE-like forms grown
without host cells (Fig. 3, A–C). IMC loss was sometimes
simultaneous with a first round of nuclear division but
these events did not occur in a synchronized fashion (Fig.
3, B and C). The IMC loss in host cell–free EEF closely re-
sembled its loss in intracellular EEF (Fig. 3 D). Lactacystin
(10 µM), a highly specific inhibitor of proteasome activity,
Figure 3. (A–D) The IMC is
lost during intracellular and host
cell-free development of trans-
formed EEF. EEF (24-h cul-
ture) stained with antibodies
against CS and MTIP, an IMC
marker. (A) An extracellular
EEF that shows complete cir-
cumferential MTIP staining in-
dicating little IMC loss. The
trophozoite has a single elongate
nucleus. (B) An extracellular
EEF showing partial IMC loss.
Two closely associated nuclei
are visible showing that this par-
asite has undergone a first round
of nuclear division. (C) An ex-
tracellular EEF showing further
IMC loss to  30% of its origi-
nal size. Two separated nuclei
are visible. (D) An EEF devel-
oping within a HepG2 cell 24 h
after infection. Loss of the IMC
occurs similar to the loss ob-
served in host cell-free develop-
ment. Nuclei in A–D are visual-
ized with DAPI. Micrographs
on the right show the corre-
sponding DIC images. (E) A
culture of EE forms expressing
GFP grown at 22 C for 24 h.
Initiation of transformation has
occurred as indicated by the
transformation bulbs (arrows).
The EEF are arrested at this
stage and do not develop into
spherical trophozoites. Bars, 10
µm. (F) rRNA type switch in
EEF grown for 24 h without
host cells. RT-PCR with type-
specific oligonucleotide primers
detects expression of A-type
rRNA in cultures grown at 22 C and 37 C. Expression of S-type rRNA is not detectable in 37 C cultures but still detectable in 22 C cultures. Con-
trols are PCR reactions without prior RT for 37 C/A-type and 22 C/S-type.T
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inhibited host cell–free transformation by 
 
 
 
70% (unpub-
lished data), indicating that EE-like transformation was a
proteasome-dependent process. This was consistent with its
previously observed inhibitory effect on sporozoite trans-
formation into intracellular EEF (22). Together, the data
show that, in the absence of intact host cells or host cell–
derived components, sporozoites transform into EEF that
undergo nuclear division and express proteins similar to
early EEF that develop within host cells.
The host cell–free culture system provides a unique op-
portunity to study what environmental factors directly gov-
ern transformation. The stimulus for transformation might
be a shift in temperature experienced by the parasite during
transmission. To test this, we incubated sporozoites at ei-
ther 22
 
 
 
C (temperature of mosquito vector) or 37
 
 
 
C (tem-
perature of mammalian host) for 24 h. In contrast to sporo-
zoites cultured at 37
 
 
 
C, sporozoites cultured at 22
 
 
 
C
initiated transformation (revealed by the occurrence of
transformation bulbs), but rarely developed into completely
spherical EEF (Fig. 3 E and Table I). Therefore, a shift
from low to high temperature is not necessary for initiation
of the transformation process but high temperature is re-
quired for complete transformation of sporozoites into
EEF. Interestingly, parasites kept at 22
 
 
 
C for 24 h could
still develop into spherical EEF when the temperature was
subsequently shifted to 37 C for 24 h (Table I), and this oc-
curred with higher efficiency of transformation ( 19%)
than in cultures directly incubated at 37 C. Thus, parasites
kept at low temperature remained viable, experiencing a
reversible arrest of transformation. In addition, we deter-
mined that the presence of serum was also critical for trans-
formation (Table I). Without serum, few parasites trans-
formed into spherical EEF and most parasites were not
detectable in 37 C cultures after 24 h.
Switching occurs between the expression of different
types of ribosomal RNA (rRNA) at transition points in the
Plasmodium life cycle (23). One such transition is the trans-
formation of sporozoites into EEF when rRNA expression
switches from S-type in sporozoites (S for sporozoite) to
A-type in EEF and succeeding blood stages (A for Asexual;
reference 24). We determined rRNA expression in the
host cell-free transformation system at 22 C and 37 C after
24 h of culture by reverse transcriptase-PCR using oligo-
nucleotide primers specific for either A-type or S-type. Ex-
pression of A-type rRNA was detected in host cell-free
EEF cultures at both temperatures (Fig. 3 F). Thus, expres-
sion of A-type rRNA was not dependent on temperature
elevation, however, it seemed to increase with the elevated
temperature. S-type rRNA was detectable at 22 C but was
not detectable at 37 C, confirming the rRNA switch (Fig.
3 F). This indicated that either the elevated temperature re-
pressed expression or that the S-type is under control of a
cold-stimulated promoter. Thermoregulation of rRNA
gene expression was described recently to also occur in the
parasites’ blood stages (25).
A central tenet of Plasmodium transmission is that the in-
vasive sporozoite must penetrate a host hepatocyte and take
up intracellular residence to initiate development into EEF.
However, we have shown that in principle, sporozoites do
not require an intact host cell or any specific host cell–
derived factors to transform into EEF. Our results suggest that
in vivo, sporozoites might initiate the transformation pro-
gram before invasion as soon as they enter the mammalian
bloodstream. After sporozoites enter the bloodstream, they
rapidly sequester in the liver and invade hepatocytes within
minutes (26). This rapid homing ensures that transformation
occurs only after invasion of a suitable host cell. Although
sporozoites can transform into EEF without host cells, intra-
cellular residence is likely to be essential for the parasites’
trophic phase when host cell–derived factors are needed for
further growth. Plasmodium merozoites can transform into
trophozoites and develop outside a red blood cell (27) only
in the presence of red cell extract, indicating that merozoite
transformation and subsequent parasite development was
dependent on some yet undefined host cell factors.
More than 50 yr after their discovery (1), the biology
and antigenic repertoire of EEF remains largely unstudied,
mainly due to the small number that can be obtained in
vivo and in vitro and the technical challenge of separating
the intracellular EEF from uninfected hepatocytes and
surrounding host hepatocytes. Sterile, protective immunity
against malaria in humans and animal models has only been
achieved by immunization with radiation-attenuated
sporozoites (5, 28, 29). Irradiated sporozoites invade hepa-
tocytes and transform into early EEF, but remain arrested at
this stage (30, 31). Thus, it is the antigens expressed in early
EEF that confer the sterile, protective immunity (32).
Therefore, identification of these antigens must be regarded
as the most important goal toward development of a
preerythrocytic malaria vaccine (5, 33, 34), and this might
be facilitated by a host cell–free transformation system.
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